Rephonic
Artwork for American Journal of Psychiatry Audio

American Journal of Psychiatry Audio

American Journal of Psychiatry
Mental Health
Schizophrenia
Substance Use Disorders
Alcohol Use Disorder
Psychiatry
Depression
Psychotic Disorders
Discrimination
Psychedelics
Stimulant Use Disorder
Clinical Trials
Psychological Distress
Premenstrual Dysphoric Disorder
Recovery
Remission
Neural Reactivity
Psilocybin
Suicidal Ideation
Depressive Disorder
Allostatic Model Of Addiction

Each episode of AJP Audio brings you an in-depth look at one of the articles featured in that month's issue of The American Journal of Psychiatry, the official journal of the American Psychiatric Association. Wide-ranging interviews with article authors cover the background, rationale, main findings, and future implications of the research. This podcast is subject to the Terms of Use at ww.psychia... more

PublishesMonthlyEpisodes235Founded19 years ago
Number of ListenersCategories
ScienceHealth & FitnessMedicine

Listen to this Podcast

Artwork for American Journal of Psychiatry Audio

Latest Episodes

Dr. Charles Conway (Washington University School of Medicine, St. Louis) joins the podcast to discuss the RECOVER trial, a RCT that looked at vagus nerve stimulation and its effects on profoundly treatment resistant depression. Following that, AJP Ed... more

Dr. Heon-Jeong Lee (Korea University, Seoul) joins AJP Audio to discuss an app-based intervention designed to help individuals with mood disorders regulate their circadian rhythms to prevent recurrence of mood episodes. Afterwards, Dr. Ned Kalin will... more

Amandeep Jutla, M.D., joins Dr. Dixon and Dr. Berezin, with guest host Dr. Matt Hirschtritt, to discuss concerns surrounding the use of large language model chatbots and psychiatric risk.

• 01:08 Introduction

• 04:03 Language models in 2019

• 05... more

Dr. Deepak Cyril D'Souza (Yale University School of Medicine) joins the podcast to discuss a study looking at two cohorts of patients hospitalized with first instances of psychosis, one with cannabis exposure and one without. Afterwards, AJP Editor-i... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Psychopharmacology and Psychiatry Updates
Psychopharmacology and Psychiatry UpdatesPsychopharmacology Institute
The Carlat Psychiatry Podcast
The Carlat Psychiatry PodcastThe Carlat Psychiatry Podcast
NEI Podcast
NEI PodcastNeuroscience Education Institute
Psychiatry Boot Camp
Psychiatry Boot CampMark Mullen, MD

Recent Guests

Charles Conway
Professor of Psychiatry at Washington University School of Medicine in St. Louis
Washington University School of Medicine
Episode: October 2026: The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions
Heon-Jeong Lee
Lead author of the circadian rhythm app study
Korea University, Seoul, South Korea
Episode: September 2026: Circadian Rhythm Stabilization App to Prevent Mood Episode Recurrence in Patients With Mood Disorders: A Multicenter, Double-Blind, Sham-Controlled, Randomized Clinical Trial
Deepak Cyril D'Souza
Professor of Psychiatry at Yale University School of Medicine
Yale University
Episode: August 2026: Cognitive, Electrophysiological, and Behavioral Presentation of First-Episode Psychosis With or Without Cannabis Exposure
Dilip Jeste
Geriatric Psychiatrist, Director of the Social Determinants of Health Network, President of the World Federation of Psychotherapy
University of California, San Diego; World Federation of Psychotherapy
Episode: July 2026: Social Determinants of Health in Psychiatric Disorders: Exciting Opportunities for Biopsychosocial Research and Clinical Care
Jason Tucciarone
Assistant Professor at Stanford University, Psychiatry and Behavioral Sciences
Stanford University
Episode: June 2026: Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
Alan Schatzberg
Director of the Stanford Mood Disorders Program and the Kenneth T. Norris Professor
Stanford University
Episode: June 2026: Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
María Oquendo
Chair of APA's Future DSM Strategic Committee
Perelman School of Medicine at the University of Pennsylvania
Episode: Special Episode: The Future of DSM
Eduardo Butelman
Author on the real-world SUD comorbidity paper
Icahn School of Medicine at Mount Sinai, New York
Episode: May 2026: Psychiatric Comorbidities in Substance Use Disorders: Sex-Based Differences in a National Real-World Clinical Sample
Ned Kalin
Commentator and expert on DSM future direction
Columbia University (epidemiology context referenced)
Episode: May 2026: Psychiatric Comorbidities in Substance Use Disorders: Sex-Based Differences in a National Real-World Clinical Sample

Hosts

Aaron Van Dorn
Host of AJP Audio
Ned Kalin
Editor-in-Chief of AJP / Commentator and expert

Reviews

4.1 out of 5 stars from 131 ratings
  • Stilted

    The guests and topics are generally very good, but the interviewer is either unwilling or unable to engage in an actual conversational exchange. It feels like questions are written in advance and read on air. There are almost no followup questions. As a result, episodes feel scripted and stilted. For examples of what a good podcast interview sounds like, see, for instance, Sean Carroll’s Mindscapes podcast or People I Mostly Admire with Steven Levitt.

    Apple Podcasts
    3
    Regina Levy
    United States4 years ago
  • Appreciate the podcasts.

    I have a 44 y.o. son with schizoaffective disorder and it is a challenge to be an effective parent

    Any practical physician advice to someone in this circumstance is greatly appreciated. I am a nurse practitioner but psychiatry is not my specialty

    It’s helpful to listen to practicing psychiatrists discuss medication and side effects.

    Keep up your good work!

    Apple Podcasts
    5
    Manlove50
    United States4 years ago
  • June podcast

    Devoid of meaningful content. Really a striking contrast from the interview w Dr Kendler, who was eloquent and informative. This one was full of jargon a missed opportunity to something insightful and specific about structural racism.

    Apple Podcasts
    2
    rabidmoderate
    United States4 years ago
  • very helpful and eye opening! I loved the insights into clinical practice! Thank you so much!

    Audible
    5
    Olgelena
    United States5 years ago
  • awesome!

    very helpful and eye opening! I loved the insights into clinical practice! Thank you so much!

    Audible
    5
    Olgelena
    United States5 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Some episodes are criticized for lack of meaningful content or jargon; others praised for reliability and academic grounding.
The host faces criticism for sounding scripted and not engaging in follow-up questions.
Listeners appreciate practical physician insights and medication discussions.
Many reviews highlight clarity and credible sourcing; some cite audio/engagement issues.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#27
Philippines/Science
Apple Podcasts
#166
Israel/Science
Apple Podcasts
#232
Japan/Science
Apple Podcasts
#232
Brazil/Science
Apple Podcasts
#246
Taiwan/Science
Apple Podcasts
#248
Argentina/Science

Talking Points

Recent interactions between the hosts and their guests.

October 2026: The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions
Q: What were the ethical considerations around using a sham control in such a trial?
Ethical concerns centered on delaying an active treatment in severely ill patients; however, the researchers argued sham control was essential to understand the true course of response and to distinguish device effects from placebo, hoping to inform better future trials.
October 2026: The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions
Q: What did the RECOVER trial find about effectiveness over time?
The trial showed that while initial outcomes at six weeks were negative, a substantial portion of patients improved over longer follow-up, with notable response and remission emerging by 12-24 months and sustained benefits in quality of life and daily functioning for many patients.
September 2026: Circadian Rhythm Stabilization App to Prevent Mood Episode Recurrence in Patients With Mood Disorders: A Multicenter, Double-Blind, Sham-Controlled, Randomized Clinical Trial
Q: What did you find in terms of mood recurrence and safety with the app-based intervention?
The study found that patients using the active circadian-stabilizing app experienced significantly fewer mood episodes over 12 months than those using the sham app, with no serious adverse events reported, though the study acknowledged limitations like adherence and lack of direct circadian biological measurements.
August 2026: Cognitive, Electrophysiological, and Behavioral Presentation of First-Episode Psychosis With or Without Cannabis Exposure
Q: What did you find?
The cannabis-exposed group was younger at admission, showed similar cognitive and positive symptoms initially, but demonstrated greater cognitive improvement after treatment and distinct EEG markers, suggesting possible subtyping within first-episode psychosis.
June 2026: Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
Q: What did you find in the study regarding buprenorphine's effect after ketamine on suicidal ideation?
We found that a low dose of sublingual buprenorphine significantly extended the anti-suicidal properties of ketamine, with participants receiving buprenorphine showing a greater and more sustained reduction in suicidality over the four-week follow-up.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About American Journal of Psychiatry Audio

What is American Journal of Psychiatry Audio about and what kind of topics does it cover?

Provides in-depth explorations of scholarly articles in each monthly issue, with interviews from authors and researchers to unpack background, methodology, findings, and practical implications. Episodes cover a broad range of psychiatric topics—from schizophrenia and suicidality to DSM evolution, social determinants of health, and novel treatment approaches—often featuring senior researchers, editors, and rising academics. Noteworthy is the strong emphasis on clinical applicability, research context, and living- document perspectives for future DSM concepts, making it a solid fit for listeners who want credible, academically grounded psychiatry content with clear connections to practice and policy.

Where can I find podcast stats for American Journal of Psychiatry Audio?

Rephonic provides a wide range of podcast stats for American Journal of Psychiatry Audio. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to American Journal of Psychiatry Audio and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does American Journal of Psychiatry Audio get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for American Journal of Psychiatry Audio, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for American Journal of Psychiatry Audio?

Rephonic provides comprehensive predictive audience data for American Journal of Psychiatry Audio, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does American Journal of Psychiatry Audio have?

To see how many followers or subscribers American Journal of Psychiatry Audio has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to American Journal of Psychiatry Audio?

These podcasts share a similar audience with American Journal of Psychiatry Audio:

1. Psychopharmacology and Psychiatry Updates
2. The Carlat Psychiatry Podcast
3. NEI Podcast
4. Psychiatry Boot Camp
5. Psychiatry & Psychotherapy Podcast

How many episodes of American Journal of Psychiatry Audio are there?

American Journal of Psychiatry Audio launched 19 years ago and published 235 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact American Journal of Psychiatry Audio?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for American Journal of Psychiatry Audio?

Rephonic pulls ratings and reviews for American Journal of Psychiatry Audio from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for American Journal of Psychiatry Audio?

Rephonic provides full transcripts for episodes of American Journal of Psychiatry Audio. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on American Journal of Psychiatry Audio?

Recent guests on American Journal of Psychiatry Audio include:

1. Charles Conway
2. Heon-Jeong Lee
3. Deepak Cyril D'Souza
4. Dilip Jeste
5. Jason Tucciarone
6. Alan Schatzberg
7. María Oquendo
8. Eduardo Butelman

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days